COSM · Cosmos Health Inc
United States · RS rating 45 · As of 2026-11-03
| Price | 0.30 USD |
|---|---|
| 1-day change | -1.6% |
| RS rating (overall / 1M / 3M / 12M) | 45 / 32 / 94 / 15 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 25 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -70.0% |
| Sales growth Q/Q | +16.0% |
| Distance from 52-week high | +60.8% |
| Market cap (USD) | $18.1M |